puc-header

The Blood-Brain Barrier is Dysregulated in COVID-19 and Serves as a CNS Entry Route for SARS-CoV-2

46 Pages Posted: 16 Apr 2021 Publication Status: Review Complete

See all articles by Susanne Krasemann

Susanne Krasemann

University of Hamburg - Institute of Neuropathology

Undine Haferkamp

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Susanne Pfefferle

University of Hamburg - Institute of Microbiology, Virology and Hygiene

Marcel Seungso Woo

University Medical Center Hamburg-Eppendorf - Institute for Neuroimmunology and Multiple Sclerosis

Fabian Heinrich

University Medical Center Hamburg-Eppendorf - Institute for Legal Medicine

Michaela Schweizer

University Medical Center Hamburg-Eppendorf - Morphology and Electron Microscopy Core Facility

Antje Appelt-Menzel

University Hospital Würzburg - Tissue Engineering and Regenerative Medicine (TERM)

Janica Barenberg

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Jennifer Leu

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Kristin Hartmann

University of Hamburg - Institute of Neuropathology

Edda Thies

University of Hamburg - Institute of Neuropathology

Jessica Lisa Littau

University of Hamburg - Institute of Neuropathology

Diego Sepulveda-Falla

University of Hamburg - Institute of Neuropathology

Liang Zhang

Nanostring Technologies

Kathy Ton

Nanostring Technologies

Yan Liang

Nanostring Technologies

Jakob Matschke

University Medical Center Hamburg-Eppendorf - Institute of Neuropathology

Franz Ricklefs

University Medical Center Hamburg-Eppendorf - Department of Neurosurgery

Thomas Sauvigny

University Medical Center Hamburg-Eppendorf - Department of Neurosurgery

Jan Sperhake

University Medical Center Hamburg-Eppendorf - Institute for Legal Medicine

Antonia Fitzek

University Medical Center Hamburg-Eppendorf - Institute for Legal Medicine

Anna Gerhartl

AIT Austrian Institute of Technology GmbH

Andreas Brachner

AIT Austrian Institute of Technology GmbH

Sören Franzenburg

University of Kiel - Institute of Clinical Molecular Biology

Andre Franke

University of Kiel - Institute of Clinical Molecular Biology

Stefan Moese

Neurimmune AG

Franz-Josef Müller

Schleswig-Holstein University - Zentrum für Integrative Psychiatrie ZIP gGmbH

Gerd Geisslinger

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Carsten Claussen

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Aimo Kannt

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Andrea Zaliani

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Philip Gribbon

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Benjamin Ondruschka

University Medical Center Hamburg-Eppendorf - Institute for Legal Medicine

Winfried Neuhaus

AIT Austrian Institute of Technology GmbH

Manuel A. Friese

University Medical Center Hamburg-Eppendorf - Institute for Neuroimmunology and Multiple Sclerosis

Markus Glatzel

University of Hamburg - Institute of Neuropathology

Ole Pless

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

More...

Abstract

Neurological complications are common in COVID-19 patients. Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been detected in patients’ brain tissues, its entry routes and resulting consequences are not well understood. Here, we report that the blood-brain barrier (BBB) and its microenvironment show pronounced upregulation of interferon signaling pathways in fatal COVID-19. Moreover, human induced pluripotent stem cell (hiPSC)-derived brain capillary endothelial-like cells (BCECs) were susceptible to SARS-CoV-2 infection and recapitulated the transcriptional changes detected in vivo . While BCECs were not compromised in their paracellular tightness, we found SARS-CoV-2 in the basolateral compartment in transwell assays after apical infection, suggesting active transcytosis of the virus across the BBB in vitro . SARS-CoV-2 entry into BCECs could be reduced by anti-spike-, anti-ACE2- and anti-NRP1-specific antibodies or the TMPRSS2 inhibitor nafamostat. Together, our data provide direct evidence for SARS-CoV-2 brain entry across the BBB resulting in an increase in interferon signaling.

Keywords: SARS-CoV-2, COVID-19, blood-brain barrier, neurovascular unit, hiPSC, infection model

Suggested Citation

Krasemann, Susanne and Haferkamp, Undine and Pfefferle, Susanne and Woo, Marcel Seungso and Heinrich, Fabian and Schweizer, Michaela and Appelt-Menzel, Antje and Barenberg, Janica and Leu, Jennifer and Hartmann, Kristin and Thies, Edda and Littau, Jessica Lisa and Sepulveda-Falla, Diego and Zhang, Liang and Ton, Kathy and Liang, Yan and Matschke, Jakob and Ricklefs, Franz and Sauvigny, Thomas and Sperhake, Jan and Fitzek, Antonia and Gerhartl, Anna and Brachner, Andreas and Franzenburg, Sören and Franke, Andre and Moese, Stefan and Müller, Franz-Josef and Geisslinger, Gerd and Claussen, Carsten and Kannt, Aimo and Zaliani, Andrea and Gribbon, Philip and Ondruschka, Benjamin and Neuhaus, Winfried and Friese, Manuel A. and Glatzel, Markus and Pless, Ole, The Blood-Brain Barrier is Dysregulated in COVID-19 and Serves as a CNS Entry Route for SARS-CoV-2. Available at SSRN: https://ssrn.com/abstract=3828200 or http://dx.doi.org/10.2139/ssrn.3828200
This version of the paper has not been formally peer reviewed.

Susanne Krasemann (Contact Author)

University of Hamburg - Institute of Neuropathology ( email )

Hamburg, D - 20246
Germany

Undine Haferkamp

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP ( email )

Hamburg
Germany

Susanne Pfefferle

University of Hamburg - Institute of Microbiology, Virology and Hygiene ( email )

Germany

Marcel Seungso Woo

University Medical Center Hamburg-Eppendorf - Institute for Neuroimmunology and Multiple Sclerosis ( email )

Martinistrasse 52
Hamburg, D - 20246
Germany

Fabian Heinrich

University Medical Center Hamburg-Eppendorf - Institute for Legal Medicine ( email )

Martinistrasse 52
Hamburg, D - 20246
Germany

Michaela Schweizer

University Medical Center Hamburg-Eppendorf - Morphology and Electron Microscopy Core Facility ( email )

Martinistrasse 52
Hamburg, D - 20246
Germany

Antje Appelt-Menzel

University Hospital Würzburg - Tissue Engineering and Regenerative Medicine (TERM) ( email )

Josef-Schneider-Straße 2
97080 Würzburg
Germany

Janica Barenberg

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP ( email )

Hamburg
Germany

Jennifer Leu

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP ( email )

Hamburg
Germany

Kristin Hartmann

University of Hamburg - Institute of Neuropathology ( email )

Hamburg, D - 20246
Germany

Edda Thies

University of Hamburg - Institute of Neuropathology ( email )

Hamburg, D - 20246
Germany

Jessica Lisa Littau

University of Hamburg - Institute of Neuropathology ( email )

Hamburg, D - 20246
Germany

Diego Sepulveda-Falla

University of Hamburg - Institute of Neuropathology ( email )

Hamburg, D - 20246
Germany

Liang Zhang

Nanostring Technologies

Seattle, WA
United States

Kathy Ton

Nanostring Technologies ( email )

Seattle, WA
United States

Yan Liang

Nanostring Technologies

Seattle, WA
United States

Jakob Matschke

University Medical Center Hamburg-Eppendorf - Institute of Neuropathology ( email )

Hamburg
Germany

Franz Ricklefs

University Medical Center Hamburg-Eppendorf - Department of Neurosurgery ( email )

Martinistrasse 52
Hamburg, D - 20246
Germany

Thomas Sauvigny

University Medical Center Hamburg-Eppendorf - Department of Neurosurgery ( email )

Martinistrasse 52
Hamburg, D - 20246
Germany

Jan Sperhake

University Medical Center Hamburg-Eppendorf - Institute for Legal Medicine ( email )

Martinistrasse 52
Hamburg, D - 20246
Germany

Antonia Fitzek

University Medical Center Hamburg-Eppendorf - Institute for Legal Medicine ( email )

Martinistrasse 52
Hamburg, D - 20246
Germany

Anna Gerhartl

AIT Austrian Institute of Technology GmbH ( email )

Donau-City-Straße 1
Vienna, 1220
Austria

Andreas Brachner

AIT Austrian Institute of Technology GmbH ( email )

Donau-City-Straße 1
Vienna, 1220
Austria

Sören Franzenburg

University of Kiel - Institute of Clinical Molecular Biology ( email )

Germany

Andre Franke

University of Kiel - Institute of Clinical Molecular Biology ( email )

Germany

Stefan Moese

Neurimmune AG ( email )

Switzerland

Franz-Josef Müller

Schleswig-Holstein University - Zentrum für Integrative Psychiatrie ZIP gGmbH ( email )

Kiel
Germany

Gerd Geisslinger

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP ( email )

Hamburg
Germany

Carsten Claussen

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP ( email )

Hamburg
Germany

Aimo Kannt

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP ( email )

Hamburg
Germany

Andrea Zaliani

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP ( email )

Hamburg
Germany

Philip Gribbon

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP ( email )

Hamburg
Germany

Benjamin Ondruschka

University Medical Center Hamburg-Eppendorf - Institute for Legal Medicine ( email )

Winfried Neuhaus

AIT Austrian Institute of Technology GmbH ( email )

Donau-City-Straße 1
Vienna, 1220
Austria

Manuel A. Friese

University Medical Center Hamburg-Eppendorf - Institute for Neuroimmunology and Multiple Sclerosis ( email )

Martinistrasse 52
Hamburg, D - 20246
Germany

Markus Glatzel

University of Hamburg - Institute of Neuropathology ( email )

Hamburg, D - 20246
Germany

Ole Pless

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP ( email )

Hamburg
Germany

Click here to go to Cell.com

Paper statistics

Downloads
51
Abstract Views
1,583
PlumX Metrics